5 completed, 4 unknown, 3 not yet recruiting, 2 recruiting. 4 Not applicable, 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Active not recruiting 1, Unknown 1 |
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Uterine Sarcoma: new trials by email Literature Review of Uterine Sarcoma trials Research Report on Uterine Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions Routine-care metastasis-directed radiotherapy - Cervical Cancer, Gynecologic Cancer | Recruiting | Affidea Nu-med Center of Oncological DIagnostics and Therapy | 500 | 2026-10-06 | 2026-10-23 | |
| A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma No intervention (observational study) - Uterine Fibroid, Uterine Sarcoma | Not yet recruiting | Tongji Hospital | 500 | 2026-09-30 | 2026-10-08 | |
| Ph 2 Elacestrant in ER Positive Uterine Sarcomas Elacestrant - Uterine Sarcoma, Uterine Leiomyosarcoma | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 30 | 2026-03-25 | 2026-05-22 |
| Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases. Ovarian Carcinoma, Cervical Carcinoma | Not yet recruiting | National Cancer Institute, Naples | 130 | 2025-12-01 | 2025-12-05 | |
| Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids No intervention (observational study) - Uterine Fibroid, Uterine Sarcoma | Enrolling by invitation | Tongji Hospital | 520 | 2025-01-01 | 2026-10-08 | |
| UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS: a MULTI -OMICS PLATFORM for IMPROVED PATIENTS MANAGEMENT DNA, RNA, ctDNA, metabolomics - Uterine Sarcoma, Vulvar Cancer | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 190 | 2024-09-15 | 2024-09-03 | |
| Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids TU-LESS, MPLS - Uterine Fibroid, Uterine Sarcoma | Not applicable | Active not recruiting | West China Second University Hospital | 5000 | 2023-06-24 | 2024-02-06 |
| Molecular Mechanism Study of Uterine Sarcoma Diagnostic biomarker - Uterine Sarcoma | Unknown | Shixuan Wang | 300 | 2023-03-01 | 2023-05-31 | |
| Construction of a Model for the Differential Diagnosis of SArcoma/myoma Based on the RAdiomics Features: Single-center Observational Study Uterine Sarcoma, Uterine Myoma | Unknown | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 176 | 2022-11-07 | 2025-02-03 | |
| The Application of Real-Time Near-infrared Imaging in Gynecological Surgery Intravenous ICG and Real-Time Near-infrared Imaging - Cervical Cancer, Ovarian Tumor | Not applicable | Unknown | Chen Chunlin | 500 | 2020-01-01 | 2020-01-14 |
| IRCI Gynae Sarcomas, High Grade Uterine Sarcoma Cabozantinib, Placebo - Uterine Sarcoma | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 58 | 2015-02-02 | 2025-08-01 |
| Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer informational intervention, counseling intervention, questionnaire administration - Anxiety Disorder, Cervical Cancer | Not applicable | Completed | University of Wisconsin, Madison | 15 | 2014-09-01 | 2019-11-18 |
| Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma Trabectedin, Drug: holiday - Soft Tissue Sarcoma, Uterine Sarcoma | Phase 2 | Completed | Centre Oscar Lambret | 53 | 2011-02-01 | 2026-03-16 |
| Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors questionnaire administration, standard follow-up care, educational intervention - Cervical Cancer, Endometrial Cancer | Not applicable | Completed | New Mexico Cancer Research Alliance | 40 | 2009-11-01 | 2013-03-07 |
| The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas doxorubicin, ifosfamide, cisplatin - Uterine Sarcoma | Phase 3 | Unknown | Gustave Roussy, Cancer Campus, Grand Paris | 270 | 2001-09-01 | 2007-08-10 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer interleukin-2, MAGE-12 peptide vaccine, Montanide ISA-51 - Lung Cancer, Adult Soft Tissue Sarcoma | Phase 1 | Completed | National Cancer Institute (NCI) | 2000-07-01 | 2024-03-04 | |
| Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020) Everolimus - Uterine Sarcoma | No longer available | The University of Texas Health Science Center at San Antonio | 2025-05-28 |
Endometrial Neoplasms (5) · Uterine Cervical Neoplasms (5) · Vulvar Neoplasms (5) · Leiomyoma (3) · Ovarian Neoplasms (3) · Carcinoma, Ovarian Epithelial (2) · Myofibroma (2) · Sarcoma (2) · Vaginal Neoplasms (2) · Adenomyosis (1) · Adenosarcoma of the uterus (1) · Anxiety Disorders (1) · Bone Neoplasms (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1)
Neoplasms (13) · Neoplasms by Histologic Type (9) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Genital Diseases (7) · Genital Diseases, Female (7) · Neoplasms by Site (7) · Neoplasms, Connective and Soft Tissue (7) · Urogenital Diseases (7) · Urogenital Neoplasms (7) · Genital Neoplasms, Female (6) · Uterine Diseases (6) · Adnexal Diseases (5) · Endocrine Gland Neoplasms (5) · Endocrine System Diseases (5)
Observation (2) · Circulating Tumor DNA (1) · Cisplatin (1) · Counseling (1) · DNA (1) · Doxorubicin (1) · Early Intervention, Educational (1) · Everolimus (1) · Ifosfamide (1) · Interleukin-2 (1) · Methods (1) · RAD1901 (1) · RNA (1) · Trabectedin (1) · Treatment Interruption (1)
Tongji Hospital (2) · Affidea Nu-med Center of Oncological DIagnostics and Therapy (1) · Centre Oscar Lambret (1) · Chen Chunlin (1) · Dana-Farber Cancer Institute (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · National Cancer Institute (NCI) (1) · National Cancer Institute, Naples (1) · New Mexico Cancer Research Alliance (1) · Shixuan Wang (1) · The University of Texas Health Science Center at San Antonio (1) · University of Wisconsin, Madison (1)
China (4) · Italy (4) · United States (4) · France (3) · Netherlands (1) · Poland (1) · Spain (1) · United Kingdom (1)
David Kushner (1) · Francesco M. Marincola (1) · Isabelle Ray-Coquard, MD (1) · Mateusz Bilski, MD, PhD (1) · Nicholas Reed, MD (1) · Patricia Pautier, Dr (1) · Suzanne George, MD (1) · Teresa Rutledge, MD (1)
PMID 25051495, PMID 25199746, PMID 25680558, PMID 26394736, PMID 28950327, PMID 29078975, PMID 29290809, PMID 29551477, PMID 29935649, PMID 31325591, PMID 32546554, PMID 34009140, PMID 35230489, PMID 36450938, PMID 36933684, PMID 37093509
P30CA014520 (1)